Fig. 2From: Trying to identify who may benefit most from future vitamin D intervention trials: a post hoc analysis from the VITDAL-ICU study excluding the early deathsUnivariate analysis. The odds ratio for 28-day mortality, for vitamin D supplementation, and for several clinically relevant covariatesBack to article page